Cue Biopharma, Inc.

Nasdaq:CUE

Pharmaceutical Preparations·BOSTON, MA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/12/25	→
10-K	FY 2024	12/31/24	3/31/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
10-Q	Q2 2024	6/30/24	8/14/24	→
↓

Earnings Releases (8-K)

10 shown

Filed	Period
11/12/25	Q4 FY2025	→
8/12/25	Q3 FY2025	→
5/12/25	Q2 FY2025	→
4/15/25	Q1 FY2025	→
3/31/25	Q1 FY2025	→
11/14/24	Q4 FY2024	→
↓

News (8-K)

61 shown

Filed	Type	Description
2/18/26	Other	Other Events	→
2/12/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/19/25	Agreement	Entry into a Material Definitive Agreement	→
11/24/25	Reg FD	Regulation FD Disclosure	→
11/20/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
11/6/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
12/19/25	424B5	424B5	→
12/18/25	424B5	424B5	→
8/12/25	S-8	S-8	→
4/25/25	ARS	ARS	→
4/15/25	424B5	424B5	→
4/14/25	424B5	424B5	→
↓

Filing History(472 filings)

TypeDateAccessionPeriodSize

PRE 14A

Mar 6, 2026

0001193125-26-096441PRE 14A

Mar 6, 2026

4.6 MB

8-K

Feb 18, 2026

0001193125-26-0569838-K

Feb 18, 2026

194.9 KB

8-K

Feb 12, 2026

0001193125-26-0477178-K

Feb 9, 2026

194.7 KB

Jan 6, 2026

0001193125-26-0043594

Jan 2, 2026

5.2 KB

Jan 6, 2026

0001193125-26-0043584

Jan 2, 2026

5.4 KB

Jan 6, 2026

0001193125-26-0043564

Jan 2, 2026

5.3 KB

Jan 6, 2026

0001193125-26-0043574

Jan 2, 2026

5.2 KB

Jan 6, 2026

0001193125-26-0043554

Jan 2, 2026

5.3 KB

Jan 6, 2026

0001193125-26-0043544

Jan 2, 2026

5.3 KB

Jan 2, 2026

0001193125-26-0009004

Dec 30, 2025

9.7 KB

144

Dec 29, 2025

0001950047-25-010720

—

4.6 KB

8-K

Dec 19, 2025

0001193125-25-3269258-K

Dec 19, 2025

636.7 KB

424B5

Dec 19, 2025

0001193125-25-326847424B5

—

591.7 KB

424B5

Dec 18, 2025

0001193125-25-324820424B5

—

593.8 KB

Dec 5, 2025

0001193125-25-3100674

Sep 26, 2025

7.6 KB

Nov 25, 2025

0001193125-25-2969864

Sep 29, 2025

5.1 KB

Nov 25, 2025

0001193125-25-2969854

Sep 29, 2025

5.2 KB

8-K

Nov 24, 2025

0001193125-25-2920938-K

Nov 24, 2025

14.7 MB

8-K

Nov 20, 2025

0001193125-25-2897138-K

Nov 17, 2025

191.6 KB

10-Q

Nov 12, 2025

0001193125-25-27746610-Q

Sep 30, 2025

8.6 MB

8-K

Nov 12, 2025

0001193125-25-2774688-K

Nov 12, 2025

398.0 KB

8-K

Nov 6, 2025

0001193125-25-2681358-K

Nov 6, 2025

298.9 KB

Oct 2, 2025

0001193125-25-2289204

Sep 29, 2025

5.2 KB

Oct 2, 2025

0001193125-25-2289193

Sep 29, 2025

20.8 KB

8-K

Sep 29, 2025

0000950130-25-0001408-K

Sep 26, 2025

215.2 KB

25 filings shown

Filed	Form	Description
12/29/25	144	144	→
5/16/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
3/21/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
10/7/24	SCHEDULE 13G/A	SCHEDULE 13G/A	→
5/26/23	EFFECT	EFFECT	→
↓

Cue Biopharma, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(472 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/6/26	PRE 14A	PRE 14A	→
5/27/25	DEFA14A	DEFA14A	→
4/25/25	DEF 14A	DEF 14A	→
4/25/25	DEFA14A	DEFA14A	→
4/14/25	PRE 14A	PRE 14A	→
9/10/24	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
1/6/26	4	4	→
1/6/26	4	4	→
1/6/26	4	4	→
1/6/26	4	4	→
1/6/26	4	4	→
1/6/26	4	4	→
↓